Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?

Tytuł:: Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Autorzy:: Spek CA; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands .
Duitman J; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands.
Źródło:: The European respiratory journal [Eur Respir J] 2020 Jun 11; Vol. 55 (6). Date of Electronic Publication: 2020 Jun 11 (Print Publication: 2020).
Typ publikacji:: Editorial; Comment
Język:: English
Imprint Name(s):: Publication: Sheffield, United Kingdom : European Respiratory Society
Original Publication: Copenhagen : Published jointly by the Society and Munksgaard, 1988-
MeSH Terms:: Bleomycin*
Idiopathic Pulmonary Fibrosis*
Humans ; Publishing
Substance Nomenclature:: 11056-06-7 (Bleomycin)
Entry Date(s):: Date Created: 20200613 Date Completed: 20201130 Latest Revision: 20201130
Update Code:: 20240105
DOI:: 10.1183/13993003.00811-2020
PMID:: 32527853
: Opinia redakcyjna

Competing Interests: Conflict of interest: C.A. Spek has nothing to disclose. Conflict of interest: J.W. Duitman has nothing to disclose.

Comment on: Eur Respir J. 2020 Jun 11;55(6):. (PMID: 32165401)

Informacja